Literature DB >> 20808111

Cognitive slowing associated with elevated serum anticholinergic activity in older individuals is decreased by caffeine use.

Robert D Nebes1, Bruce G Pollock, Edythe M Halligan, Patricia Houck, Judith A Saxton.   

Abstract

OBJECTIVES: This study examined whether some of the age-associated decrements in basic cognitive resources (information-processing speed and working memory) result from anticholinergic medication use (as measured by serum anticholinergic activity [SAA]) and whether such decrements are lessened by caffeine.
DESIGN: Cross-sectional observational study.
SETTING: University medical center. PARTICIPANTS: One hundred fifty-two normal-elderly community volunteers. MEASUREMENTS: Two tests each of information-processing speed and of working memory were administered, and blood samples were drawn before and after cognitive testing to determine serum levels of anticholinergic activity and of paraxanthine-a caffeine metabolite.
RESULTS: Elevated SAA was associated with a significant but modest slowing in information-processing time but only in those individuals who had low levels of serum paraxanthine. SAA did not correlate with performance on tests of working memory.
CONCLUSIONS: These results suggest that anticholinergic medications are a relatively minor contributor to the decrements in basic processing resources commonly found in studies of normal aging.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20808111      PMCID: PMC3000871          DOI: 10.1097/JGP.0b013e3181e4490d

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  30 in total

1.  Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium.

Authors:  L Tune; S Carr; E Hoag; T Cooper
Journal:  Am J Psychiatry       Date:  1992-10       Impact factor: 18.112

2.  Age-related decreases in muscarinic cholinergic receptor binding in the human brain measured with positron emission tomography (PET).

Authors:  S L Dewey; N D Volkow; J Logan; R R MacGregor; J S Fowler; D J Schlyer; B Bendriem
Journal:  J Neurosci Res       Date:  1990-12       Impact factor: 4.164

3.  Probability of stroke: a risk profile from the Framingham Study.

Authors:  P A Wolf; R B D'Agostino; A J Belanger; W B Kannel
Journal:  Stroke       Date:  1991-03       Impact factor: 7.914

4.  Anticholinergic activity of 107 medications commonly used by older adults.

Authors:  Marci L Chew; Benoit H Mulsant; Bruce G Pollock; Mark E Lehman; Andrew Greenspan; Ramy A Mahmoud; Margaret A Kirshner; Denise A Sorisio; Robert R Bies; Georges Gharabawi
Journal:  J Am Geriatr Soc       Date:  2008-05-26       Impact factor: 5.562

Review 5.  The processing-speed theory of adult age differences in cognition.

Authors:  T A Salthouse
Journal:  Psychol Rev       Date:  1996-07       Impact factor: 8.934

6.  Age and sex as factors modifying the function of the blood-cerebrospinal fluid barrier.

Authors:  C Pakulski; L Drobnik; B Millo
Journal:  Med Sci Monit       Date:  2000 Mar-Apr

7.  Age-related decline in central cholinergic function demonstrated with scopolamine.

Authors:  P N Tariot; S V Patel; C Cox; R E Henderson
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

8.  Assessment of caffeine exposure: caffeine content of beverages, caffeine intake, and plasma concentrations of methylxanthines.

Authors:  A Lelo; J O Miners; R Robson; D J Birkett
Journal:  Clin Pharmacol Ther       Date:  1986-01       Impact factor: 6.875

9.  The anticholinergic risk scale and anticholinergic adverse effects in older persons.

Authors:  James L Rudolph; Marci J Salow; Michael C Angelini; Regina E McGlinchey
Journal:  Arch Intern Med       Date:  2008-03-10

10.  Nicotinic versus muscarinic blockade alters verbal working memory-related brain activity in older women.

Authors:  Julie A Dumas; Andrew J Saykin; Brenna C McDonald; Thomas W McAllister; Mary L Hynes; Paul A Newhouse
Journal:  Am J Geriatr Psychiatry       Date:  2008-04       Impact factor: 4.105

View more
  4 in total

1.  The greater sensitivity of elderly APOE ε4 carriers to anticholinergic medications is independent of cerebrovascular disease risk.

Authors:  Robert D Nebes; Bruce G Pollock; Subashan Perera; Edythe M Halligan; Judith A Saxton
Journal:  Am J Geriatr Pharmacother       Date:  2012-04-24

Review 2.  The interplay between gait, falls and cognition: can cognitive therapy reduce fall risk?

Authors:  Orit Segev-Jacubovski; Talia Herman; Galit Yogev-Seligmann; Anat Mirelman; Nir Giladi; Jeffrey M Hausdorff
Journal:  Expert Rev Neurother       Date:  2011-07       Impact factor: 4.618

3.  Donepezil plus estradiol treatment enhances learning and delay-dependent memory performance by young ovariectomized rats with partial loss of septal cholinergic neurons.

Authors:  R B Gibbs; A M Chipman; D Nelson
Journal:  Horm Behav       Date:  2011-02-03       Impact factor: 3.587

Review 4.  Serum Anticholinergic Activity and Cognitive and Functional Adverse Outcomes in Older People: A Systematic Review and Meta-Analysis of the Literature.

Authors:  Mohammed Saji Salahudeen; Te-Yuan Chyou; Prasad S Nishtala
Journal:  PLoS One       Date:  2016-03-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.